ImMucin: Potential cancer vaccine enters clinical trials

7af903ff7f80772debd8da0e5368a69f

In May, Vaxil BioTherapeutics Ltd., a private clinical stage biopharmaceutical company, announced that its researchers had published pre-clinical results from ImMucin, Vaxil’s lead therapeutic cancer vaccine, in the May edition of the scientific journal Vaccine.

The article entitled “ImMucin: a novel therapeutic vaccine with promiscuous MHC binding for the treatment of MUC1-expressing tumors”. Like a traditional vaccine, ImMucin helps the body’s immune system fight off bacteria or viruses — but unlike common vaccine, ImMucin is administered to people who are already sick.

ImMucin activates the immune system by
“training” T-cells which protect the body by
searching out and destroying cells that display a specific molecule called MUC1. MUC1 is generally found only on cancer cells and
not on healthy cells. The implications of this are that the T-cells won’t attack any cells that don’t contain MUC1, which means that the patient won’t experience the side effects which one experiences with traditional cancer treatments. With more than 90% of cancers having MUC1 on their cells, the implications could be groundbreaking.

In September, Vaxil also announced that it had
submitted a patent application to the United States Patent Office dealing with a novel use of signal peptides and naturally
generated auto-antibodies which would allow them to detect illnesses such as cancer earlier and provide a prognosis.

Dr. Lior Carmon, founder and CEO said in the press release in Nes-Ziona, “We have succeeded in identifying a
novel way to detect cancer onset and progression. This is an invaluable
tool which will significantly enhance our ability to provide effective
relief to these patients who are eligible to be treated with ImMucin and
is yet another validation of our VaxHit technology.”

ImMucin is
currently being evaluated in a Phase I/II clinical trial in Multiple
Myeloma patients at Hadassah Medical Center, Jerusalem. ImMucin is
potentially applicable to over 90% of all types of cancer, including
both solid and non-solid tumors. The vaccine aims to activate a compromised immune system and mobilize against the threat.


News
Entertainment
Sports
Lifestyle
National

Florida man charged with murdering son to play…

A Florida man annoyed that his 16-month-old crying son was preventing him from playing video games suffocated the toddler, police said on Friday.

International

Powerful 7.2 magnitude earthquake rattles Mexico

A powerful earthquake struck Mexico Friday, shaking buildings and sending people running into the street, although there were no reports of major damage.

News

OMG! Exercise can make skin (and butt) look…

A moderate exercise regime can turn back time and actually reverse the skin's aging process, according to new research. The study showed that a minimum…

International

Jews in eastern Ukraine ordered to register, Kerry…

Secretary of State John Kerry condemned reports that Jews in eastern Ukraine had been ordered to register with the authorities "or suffer the consequences."

Entertainment

Whoopi Goldberg makes her debut as marijuana columnist

"It helps my head stop hurting, and with glaucoma your eyes ache, and she takes the ache out. It's wonderful," she said.

The Word

Kate Middleton made fun of Prince William's bald…

Kate Middleton and Prince William are in Sydney, Australia, right now, and it sounds like that brash Aussie sense of humor might be rubbing off.

The Word

Is Tom Cruise dating Laura Prepon?

"Mission: Impossible" star Cruise is said to be dating Laura Prepon, star of "Orange is the New Black."

Television

'Scandal' recap: Season 3, Episode 18, 'The Price…

Sally is Jesus, Olivia caused global warming, and Mellie's still drunk. Let's recap the Scandal finale. A church full of Washington insiders is about to…

NBA

Carmelo Anthony agonizing over Knicks future as season…

There’s still the cloud hanging over the franchise’s head as to the pending free-agent status of All-Star forward Carmelo Anthony.

NFL

Jets host players with eye toward NFL Draft

The Jets hosted a number of NFL Draft hopefuls for workouts on Thursday, with an eye toward some under-the-radar players.

NFL

Chris Johnson: I wanted to go to 'a…

Now that Chris Johnson is a Jet, the team has to figure out if one of the most explosive players in the NFL over the last half decade has anything…

NHL

Rangers' speed versus Flyers' size makes interesting playoff…

Among the myriad aspects that will make this Metropolitan Division semifinal series fascinating will be the battle between the Rangers' speed and the Flyers' size,…

Tech

VIDEO: 'Vein-scanning' may become the future of paying

Designed to make transactions quicker and easier, the technology works by scanning the unique vein patterns in each person's palm.

Tech

#FollowFriday: 10 of the smartest Twitter accounts

Spending lots of time on Twitter? You might as well learn something. Here are some of the smartest accounts to follow.

Style

Light-up nail art syncs with phone

This Japanese technology syncs light-up nail art with your phone.

Wellbeing

Why is dance cardio taking off in NYC?

Instructors at some of the city's hottest classes explain why.